Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19955
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTrubiano, Jason-
dc.contributor.authorSmibert, Olivia-
dc.contributor.authorDouglas, Abby-
dc.contributor.authorDevchand, Misha-
dc.contributor.authorLambros, Belinda-
dc.contributor.authorHolmes, Natasha E-
dc.contributor.authorChua, Kyra Y L-
dc.contributor.authorPhillips, Elizabeth J-
dc.contributor.authorSlavin, Monica A-
dc.date2018-11-17-
dc.date.accessioned2018-12-17T00:55:59Z-
dc.date.available2018-12-17T00:55:59Z-
dc.date.issued2018-12-
dc.identifier.citationOpen forum infectious diseases 2018; 5(12): ofy306-
dc.identifier.issn2328-8957-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19955-
dc.description.abstractAntibiotic allergies are reported by up to 1 in 4 cancer patients, almost 50% of which are considered low risk and precede the cancer diagnosis. We demonstrate the successful and safe implementation of a pilot oral penicillin challenge program for cancer patients with low-risk penicillin allergies, increasing the use of penicillin and narrow-spectrum beta-lactams post-testing.-
dc.language.isoeng-
dc.subjectbeta-lactam allergy-
dc.subjectimmunocompromised host-
dc.subjectoral challenge-
dc.subjectoral provocation-
dc.subjectpenicillin allergy-
dc.titleThe Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study.-
dc.typeJournal Article-
dc.identifier.journaltitleOpen forum infectious diseases-
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationThe National Centre for Infections in Cancer, Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia-
dc.identifier.affiliationCentre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Infectious Diseases, Vanderbilt University Medical Centre, Nashville, Tennessee-
dc.identifier.doi10.1093/ofid/ofy306-
dc.identifier.orcid0000-0002-5111-6367-
dc.identifier.pubmedid30547046-
dc.type.austinJournal Article-
local.name.researcherChua, Kyra Y L-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
crisitem.author.deptPharmacy-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
crisitem.author.deptMicrobiology-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

38
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.